A. O. Mueck

2.1k total citations
80 papers, 1.5k citations indexed

About

A. O. Mueck is a scholar working on Genetics, Endocrinology, Diabetes and Metabolism and Pathology and Forensic Medicine. According to data from OpenAlex, A. O. Mueck has authored 80 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Genetics, 33 papers in Endocrinology, Diabetes and Metabolism and 23 papers in Pathology and Forensic Medicine. Recurrent topics in A. O. Mueck's work include Estrogen and related hormone effects (60 papers), Menopause: Health Impacts and Treatments (30 papers) and Phytoestrogen effects and research (23 papers). A. O. Mueck is often cited by papers focused on Estrogen and related hormone effects (60 papers), Menopause: Health Impacts and Treatments (30 papers) and Phytoestrogen effects and research (23 papers). A. O. Mueck collaborates with scholars based in Germany, China and Australia. A. O. Mueck's co-authors include Harald Seeger, Xiangyan Ruan, D. Wallwiener, Santiago Palacios, Rossella E. Nappi, David Portman, Tanja Fehm, Hans Neubauer, T. H. Lippert and Jens Huober and has published in prestigious journals such as PLoS ONE, Life Sciences and The Journal of Steroid Biochemistry and Molecular Biology.

In The Last Decade

A. O. Mueck

76 papers receiving 1.5k citations

Peers

A. O. Mueck
H.J. Kloosterboer Netherlands
K. Pollow Germany
B.N. Díaz-Chico Spain
J Cortés-Prieto Spain
Kristin K. Deeb United States
Ruth A. Henderson United States
Douglas B. Muchmore United States
D.W. Killinger Canada
Fernand Labrie Canada
Salama A. Salama United States
H.J. Kloosterboer Netherlands
A. O. Mueck
Citations per year, relative to A. O. Mueck A. O. Mueck (= 1×) peers H.J. Kloosterboer

Countries citing papers authored by A. O. Mueck

Since Specialization
Citations

This map shows the geographic impact of A. O. Mueck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. O. Mueck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. O. Mueck more than expected).

Fields of papers citing papers by A. O. Mueck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. O. Mueck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. O. Mueck. The network helps show where A. O. Mueck may publish in the future.

Co-authorship network of co-authors of A. O. Mueck

This figure shows the co-authorship network connecting the top 25 collaborators of A. O. Mueck. A scholar is included among the top collaborators of A. O. Mueck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. O. Mueck. A. O. Mueck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ruan, Xiangyan & A. O. Mueck. (2023). The WHO claims estrogens are ‘carcinogenic’: is this true?. Climacteric. 26(3). 263–270. 4 indexed citations
2.
Ruan, Xiangyan, et al.. (2023). PGRMC1 promotes triple-negative breast cancer cell growth via suppressing ferroptosis. Climacteric. 26(2). 135–142. 13 indexed citations
3.
Zhang, Limei, et al.. (2022). E2 + norethisterone promotes the PI3K–AKT pathway via PGRMC1 to induce breast cancer cell proliferation. Climacteric. 25(5). 467–475. 9 indexed citations
4.
Ruan, Xiangyan & A. O. Mueck. (2022). Primary choice of estrogen and progestogen as components for HRT: a clinical pharmacological view. Climacteric. 25(5). 443–452. 7 indexed citations
5.
Ruan, Xiangyan, et al.. (2021). Genitourinary syndrome of menopause in Chinese perimenopausal and postmenopausal women. Climacteric. 24(3). 297–304. 7 indexed citations
6.
Ruan, Xiangyan, et al.. (2017). Use of cyproterone acetate/ethinylestradiol in polycystic ovary syndrome: rationale and practical aspects. The European Journal of Contraception & Reproductive Health Care. 22(3). 183–190. 27 indexed citations
7.
Shapiro, S., T. J. de Villiers, Amos Pines, et al.. (2014). Risks and benefits of hormone therapy: has medical dogma now been overturned?. Climacteric. 17(3). 215–222. 13 indexed citations
8.
9.
Neubauer, Hans, Qi Ma, Jiaolin Zhou, et al.. (2013). Possible role of PGRMC1 in breast cancer development. Climacteric. 16(5). 509–513. 44 indexed citations
10.
Bühling, Kai J., et al.. (2013). Attitude of German women towards hormone therapy: results of a lay survey. Gynecological Endocrinology. 29(5). 460–464. 2 indexed citations
11.
Ruan, Xiangyan, Hans Neubauer, Yunmei Yang, et al.. (2012). Progestogens and membrane-initiated effects on the proliferation of human breast cancer cells. Climacteric. 15(5). 467–472. 48 indexed citations
12.
Seeger, Harald & A. O. Mueck. (2010). Estradiol Metabolites and their Possible Role in Gynaecological Cancer. 7(1). 62–66. 1 indexed citations
13.
Merki‐Feld, Gabriele S., Harald Seeger, & A. O. Mueck. (2008). Comparison of the Proliferative Effects of Ethinylestradiol on Human Breast Cancer Cells in an Intermittent and a Continuous Dosing Regime. Hormone and Metabolic Research. 40(3). 206–209. 3 indexed citations
14.
Seeger, Harald, D. Wallwiener, & A. O. Mueck. (2005). Different effects of estradiol and various antiestrogens on TNF-α-induced changes of biochemical markers for growth and invasion of human breast cancer cells. Life Sciences. 78(13). 1464–1468. 23 indexed citations
15.
Mueck, A. O., Harald Seeger, & D. Wallwiener. (2004). Endogenous estradiol metabolism during treatment with oral contraceptives. International Journal of Clinical Pharmacology and Therapeutics. 42(3). 160–164. 3 indexed citations
16.
Mueck, A. O., et al.. (2003). Effects of tibolone on human breast cancer cells and human vascular coronary cells. Archives of Gynecology and Obstetrics. 267(3). 139–144. 12 indexed citations
17.
Mueck, A. O., et al.. (2001). Angiogenetic and Anti-Angiogenetic Effects of Estradiol and its Metabolites. Journal of clinical and basic cardiology. 4(2). 153–155. 5 indexed citations
18.
Mueck, A. O., et al.. (2001). The Effects of Postmenopausal Hormone Replacement Therapy and Oral Contraceptives on the Endogenous Estradiol Metabolism. Hormone and Metabolic Research. 33(12). 744–747. 12 indexed citations
19.
20.
Seeger, Harald, Franz Paul Armbruster, A. O. Mueck, & T. H. Lippert. (1998). The effect of estradiol on urodilatin production in postmenopausal women. Archives of Gynecology and Obstetrics. 262(1-2). 65–68. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by H.J. Kloosterboer Breakdown of academic impact, for papers by K. Pollow Breakdown of academic impact, for papers by B.N. Díaz-Chico Breakdown of academic impact, for papers by J Cortés-Prieto Breakdown of academic impact, for papers by Kristin K. Deeb Breakdown of academic impact, for papers by Ruth A. Henderson Breakdown of academic impact, for papers by Douglas B. Muchmore Breakdown of academic impact, for papers by D.W. Killinger Breakdown of academic impact, for papers by Fernand Labrie Breakdown of academic impact, for papers by Salama A. Salama
Rankless by CCL
2026